Health
Convalescent plasma reduced death rate among COVID-19 patients, study signals – The Australian
COVID-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50 per cent, according to researchers running a large US study.
- By Amy Dockser Marcus
- The Wall Street Journal
- 7:29PM August 5, 2020
- Comments
COVID-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50 per cent, according to researchers running a large US study.
The researchers presented their data analysis over the weekend in a webinar for physicians interested in learning about so-called convalescent plasma, with data slides that w…
Continue Reading
